1. J Clin Oncol. 2023 Jul 20;41(21):3679-3681. doi: 10.1200/JCO.23.00983. Epub
2023  Jun 4.

Encorafenib and Binimetinib: A New Treatment Option for BRAF(V600E)-Mutant 
Non-Small-Cell Lung Cancer.

Stinchcombe TE(1).

Author information:
(1)Division of Medical Oncology, Duke Cancer Institute, Durham, NC.

Comment on
    J Clin Oncol. 2023 Jul 20;41(21):3700-3711. doi: 10.1200/JCO.23.00774.

DOI: 10.1200/JCO.23.00983
PMID: 37270690 [Indexed for MEDLINE]